A case of eczematous eruption occurring during treatment with risankizumab

Ital J Dermatol Venerol. 2023 Feb;158(1):64-65. doi: 10.23736/S2784-8671.22.07360-1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal
  • Eczema* / chemically induced
  • Eczema* / drug therapy
  • Exanthema*
  • Humans

Substances

  • risankizumab
  • Antibodies, Monoclonal